News from mylan inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 16, 2014, 07:30 ET
Mylan (PRNewsFoto/Mylan)

Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®

 Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical...

Sep 15, 2014, 06:30 ET
Mylan (PRNewsFoto/Mylan)

Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries

 Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences,...

Sep 10, 2014, 07:00 ET
Mylan (PRNewsFoto/Mylan)

Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S....

Sep 08, 2014, 07:00 ET
Mylan (PRNewsFoto/Mylan)

Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™

 Mylan Inc. (Nasdaq: MYL) today commented on a ruling by the U.S. District Court for the District of Maryland related to its product,...

Sep 05, 2014, 07:30 ET
Mylan (PRNewsFoto/Mylan)

Mylan Launches Generic Boniva® Injection

Mylan Inc. (Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled...

Aug 28, 2014, 11:21 ET
Mylan (PRNewsFoto/Mylan)

Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA

 Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate...

Aug 25, 2014, 08:01 ET

Ready2Go™ Draft Winners Join Pro Football MVP Adrian Peterson in Educational Video About Anaphylaxis Preparedness

Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player and EpiPen®...

Aug 22, 2014, 07:30 ET

Mylan Launches First Generic Klor-Con® Extended-Release Tablets

 Mylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750...

Aug 19, 2014, 11:42 ET
Mylan (PRNewsFoto/Mylan)

Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

 Mylan Inc. (Nasdaq: MYL) announced that its business Mylan Institutional has launched Dexmedetomidine Hydrochloride Injection, 100 mcg...

Aug 11, 2014, 07:30 ET

Mylan Launches Generic Xeloda® Tablets

Mylan Inc. (Nasdaq: MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's...

Aug 07, 2014, 06:30 ET

Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance

Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and six months ended June 30, 2014. Second Quarter 2014...

Jul 23, 2014, 07:00 ET
Mylan (PRNewsFoto/Mylan)

Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR

Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining...

Jul 17, 2014, 07:00 ET
Mylan (PRNewsFoto/Mylan)

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product

 Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent...

Jul 16, 2014, 05:22 ET

Mylan übernimmt den Abbott-Geschäftsbereich Spezial- und Markengenerika für entwickelte Märkte außerhalb der USA im Rahmen einer reinen Aktientransaktion

- Übernahme eines attraktiven, differenzierten Produktportfolios und einer erweiterten kommerziellen Plattform, die Mylans Geschäfte...

Jul 15, 2014, 14:39 ET
Mylan (PRNewsFoto/Mylan)

Mylan adquiere el negocio de genéricos comercializados y especializados de mercados desarrollados no estadounidenses

- Mylan adquiere el negocio de genéricos comercializados y especializados de mercados desarrollados no estadounidenses de Abbott en una...

Jul 14, 2014, 06:30 ET
Mylan (PRNewsFoto/Mylan)

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

 Mylan Inc. (NASDAQ: MYL) today announced that it has entered into a definitive agreement with Abbott (NYSE: ABT) whereby Mylan will acquire...

Jul 08, 2014, 07:30 ET

Mylan Launches Generic Micardis® Tablets

Mylan Inc. (Nasdaq: MYL) today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer...

Jul 01, 2014, 13:02 ET
Mylan (PRNewsFoto/Mylan)

Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014

 Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast on Thursday, Aug. 7, 2014, at 10:00 a.m. ET...

Jun 11, 2014, 11:49 ET

Mylan Launches Generic Actonel® Tablets, 150 mg

Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's...